Maternal obesity, pregnancy weight gain, and birth weight and risk of colorectal cancer.


Journal

Gut
ISSN: 1468-3288
Titre abrégé: Gut
Pays: England
ID NLM: 2985108R

Informations de publication

Date de publication:
07 2022
Historique:
received: 22 04 2021
accepted: 28 07 2021
pubmed: 26 8 2021
medline: 10 6 2022
entrez: 25 8 2021
Statut: ppublish

Résumé

Colorectal cancer (CRC) is a leading cause of cancer-related death worldwide. Obesity is a well-established risk factor for CRC, and fetal or developmental origins of obesity may underlie its effect on cancer in adulthood. We examined associations of maternal obesity, pregnancy weight gain, and birth weight and CRC in adult offspring. The Child Health and Development Studies is a prospective cohort of women receiving prenatal care between 1959 and 1966 in Oakland, California (N=18 751 live births among 14 507 mothers). Clinical information was abstracted from mothers' medical records 6 months prior to pregnancy through delivery. Diagnoses of CRC in adult (age ≥18 years) offspring were ascertained through 2019 by linkage with the California Cancer Registry. We used Cox proportional hazards models to estimate adjusted HR (aHR); we examined effect measure modification using single-referent models to estimate the relative excess risk due to interaction (RERI). 68 offspring were diagnosed with CRC over 738 048 person-years of follow-up, and half (48.5%) were diagnosed younger than age 50 years. Maternal obesity (≥30 kg/m Our results suggest that in utero events are important risk factors for CRC and may contribute to increasing incidence rates in younger adults.

Identifiants

pubmed: 34429385
pii: gutjnl-2021-325001
doi: 10.1136/gutjnl-2021-325001
pmc: PMC8866526
mid: NIHMS1730757
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

1332-1339

Subventions

Organisme : NCI NIH HHS
ID : R01 CA242558
Pays : United States

Commentaires et corrections

Type : CommentIn

Informations de copyright

© Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: CM reports consulting for Freenome; AGS reports consulting/advisory boards for Bayer, Eisai, Genentech, BMS, Exelixis, Exact Sciences, and GRAIL; PMC, NYK, ML, TZ, EB and BAC have no financial disclosures or conflicts of interest.

Auteurs

Caitlin C Murphy (CC)

School of Public Health, The University of Texas Health Science Center at Houston, Houston, Texas, USA caitlin.c.murphy@uth.tmc.edu.

Piera M Cirillo (PM)

Child Health and Development Studies, Public Health Institute, Oakland, California, USA.

Nickilou Y Krigbaum (NY)

Child Health and Development Studies, Public Health Institute, Oakland, California, USA.

Amit G Singal (AG)

Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas, USA.

MinJae Lee (M)

Population and Data Sciences, University of Texas Southwestern Medical Center, Dallas, Texas, USA.

Timothy Zaki (T)

Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas, USA.

Ezra Burstein (E)

Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas, USA.

Barbara A Cohn (BA)

Child Health and Development Studies, Public Health Institute, Oakland, California, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH